Benefit of Paclitaxel in estrogen receptor-negative versus estrogen receptor-positive early breast cancer

J Clin Oncol. 2003 Dec 1;21(23):4465; author reply 4465-6. doi: 10.1200/JCO.2003.99.101.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antineoplastic Agents, Phytogenic / therapeutic use*
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / metabolism
  • Breast Neoplasms / secondary
  • Female
  • Humans
  • Paclitaxel / therapeutic use*
  • Prognosis
  • Receptors, Estrogen / analysis*

Substances

  • Antineoplastic Agents, Phytogenic
  • Receptors, Estrogen
  • Paclitaxel